Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionOral selective pan HER/VEGFR-2 receptor tyrosine kinase inhibitor
Molecular Target Epidermal growth factor receptor (EGFR) ; Vascular endothelial growth factor (VEGF) receptor
Mechanism of ActionEpidermal growth factor (EGF) receptor agonist; Vascular endothelial growth factor (VEGF) inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today